Fed Sinks Markets
Health Care: Drugs
Discovery Laboratories Inc. (DSCO: NASDAQ)
$1.66 -0.05 | -2.92%
06/19/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| DSCO | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -25.97 | -26.61 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -66.50 | 0.00 | 0.00 |
| Net Income | 0.23 | 0.00 | |
| EPS | -0.76 | 0.00 |
Earnings for DSCO:
| EBITDA | -37.00 |
| REVENUE | 195.00K |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.29 | $-0.22 | $-1.05 | $-0.43 |
| Number of Analysts | 2 | 2 | 2 | 2 |
| High Estimate | $-0.27 | $-0.18 | $-1.00 | $-0.35 |
| Low Estimate | $-0.30 | $-0.26 | $-1.10 | $-0.50 |
| Prior Year | $-0.17 | $-0.26 | $-0.96 | $-1.05 |
| Growth Rate (Year over Year) | -67.65% | 15.38% | -9.38% | 59.52% |
Portfolios with DSCO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserKJP Spring Break
- ContributorStocks Under-$10 Setting Up...
- UserSmall Cap Stocks
- Userjet189 Portfolio 1
- Uservolume spike
- Usermoon_in_mood Portfolio 1
- UserDtech Portfolio 1
Latest DSCO Headlines from TheStreet
- 5 Stocks Under $10 Set to Explode 02.14.13 | 01:02 pm
- Discovery Labs Receives New US Patent For Pulmonary Surfactant Formulations 01.17.13 | 07:01 am
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- Discovery Labs To Present At The Stifel Nicolaus Healthcare Conference 2012 09.04.12 | 07:09 am
- 8 Stocks Under $10 Surging Higher 08.28.12 | 02:08 pm
- 7 Stocks Under $10 With Relative Strength 07.06.12 | 02:07 pm
- 5 Stocks Under $10 Poised for Upside 04.27.12 | 11:04 am
- For Biotech Takeovers, Timing is Key 04.04.12 | 06:04 am
- For Biotech, 'Fail' is Making a Big Comeback 03.12.12 | 08:03 am
- Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail 03.09.12 | 05:03 am
Press Releases for DSCO
- Discovery Labs Receives FDA Recommendations And Request For Clarification Regarding Recently-Submitted SURFAXIN® (lucinactant) Updated Product Specifications - PR Newswire 04.15.13 | 07:04 am
- Discovery Labs Announces Newly-Released SURFAXIN® (lucinactant) Publications - PR Newswire 03.29.13 | 07:03 am
- Discovery Labs To Report Fourth Quarter 2012 Results And Hold Conference Call On Wednesday, March 13, 2013 - PR Newswire 03.06.13 | 04:03 pm
- Discovery Labs Receives $30 Million Funding Commitment From Deerfield Management - PR Newswire 02.13.13 | 04:02 pm
- Discovery Labs Announces Changes To Board Of Directors And Appoints A New Chief Executive Officer - PR Newswire 01.04.13 | 08:01 am
- Discovery Labs Initiates Launch Of AFECTAIR® - PR Newswire 01.03.13 | 07:01 am
- New Pharmacoeconomic Analysis Shows Lower Rate Of Reintubation Observed With SURFAXIN® Treatment May Reduce Hospital Costs Associated With Bronchopulmonary Dysplasia - PR Newswire 12.04.12 | 07:12 am
- Discovery Labs Presents New SURFAXIN® And AFECTAIR® Data At 2012 Hot Topics In Neonatology Annual Meeting - PR Newswire 11.28.12 | 07:11 am
- Discovery Labs Appoints John R. Leone To Board Of Directors - PR Newswire 11.14.12 | 07:11 am
- Discovery Labs Provides Commercial Update For SURFAXIN® And AFECTAIR® - PR Newswire 10.24.12 | 07:10 am
Partner Headlines for DSCO
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha 03.30.12 | 09:03 am
- Discovery Labs Down 17% After Public Offering Announcement - Benzinga 03.16.12 | 09:03 am
- Company News for March 8, 2012 - Corporate Summary - Zacks 03.08.12 | 10:03 am
- Discovery Labs Up 33% After Surfaxin Approved by the FDA - Benzinga 03.07.12 | 09:03 am
- Discovery Labs Announces FDA Approval of SURFAXIN for Prevention of Respiratory Distress Syndrome - Benzinga 03.06.12 | 04:03 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.15.11 | 09:11 am
- UPDATE 1-Discovery Labs' cystic fibrosis drug gets orphan status - Reuters 11.01.10 | 08:11 am
- UPDATE 1-Discovery Labs lung drug disappoints in mid-stage trial - Reuters 06.09.10 | 08:06 am
- FDA, Clinical Trial News: Discovery Labs, Hospira, Javelin Pharma - Seeking Alpha 05.20.10 | 06:05 am
